News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
News
Business
Taro Pharmaceutical Industries Ltd. Provides Preliminary Third Quarter and Year-to-Date 2008 Financial Results
November 11, 2008
|
1 min read
Twitter
LinkedIn
Facebook
Email
Print
HAWTHORNE, N.Y.--(BUSINESS WIRE)--Taro Pharmaceutical Industries Ltd. (“Taro,” the “Company,” Pink Sheets: TAROF) today provided information on its financial performance for the third quarter and first nine months of 2008.
Twitter
LinkedIn
Facebook
Email
Print
Earnings
MORE ON THIS TOPIC
Manufacturing
BioNTech to close German manufacturing plants after failing to find buyers
September 30, 2026
·
2 min read
·
Nick Paul Taylor
Layoff Tracker
Novo, BioMarin, Enanta dole out pink slips
September 30, 2026
·
98 min read
·
BioSpace Editorial Staff
FDA
AstraZeneca buys into Summit, UniQure drops on 4-year data, FDA on a roll
September 30, 2026
·
1 min read
·
Jef Akst
Business
Summit snags $2B investment from AstraZeneca, clearing financial overhang
September 29, 2026
·
3 min read
·
Tristan Manalac